Pathways to breast cancer screening artificial intelligence algorithm validation
Access status:
Open Access
Type
ArticleAbstract
As more artificial intelligence (AI)-enhanced mammography screening tools enter the clinical market, greater focus will be placed on external validation in diverse patient populations. In this viewpoint, we outline lessons learned from prior efforts in this field, the need to ...
See moreAs more artificial intelligence (AI)-enhanced mammography screening tools enter the clinical market, greater focus will be placed on external validation in diverse patient populations. In this viewpoint, we outline lessons learned from prior efforts in this field, the need to validate algorithms on newer screening technologies and diverse patient populations, and conclude by discussing the need for a framework for continuous monitoring and recalibration of these AI tools. Sufficient validation and continuous monitoring of emerging AI tools for breast cancer screening will require greater stakeholder engagement and the creation of shared policies and guidelines.
See less
See moreAs more artificial intelligence (AI)-enhanced mammography screening tools enter the clinical market, greater focus will be placed on external validation in diverse patient populations. In this viewpoint, we outline lessons learned from prior efforts in this field, the need to validate algorithms on newer screening technologies and diverse patient populations, and conclude by discussing the need for a framework for continuous monitoring and recalibration of these AI tools. Sufficient validation and continuous monitoring of emerging AI tools for breast cancer screening will require greater stakeholder engagement and the creation of shared policies and guidelines.
See less
Date
2020Source title
The BreastVolume
52Publisher
ElsevierFunding information
Breast Cancer Institute P01 CA154292
American Cancer Society MRSG-14-160-01-CPHPS
National Cancer Institute R37 CA240403
National Cancer Institute (R01 CA225585; U01 CA231782; R01 CA200690; R01 CA201376)
Patient Centered Outcomes Research Institute (PCS-1504-30370)
National Cancer Institute National Cancer Institute (R01CA207375, R01CA222090, UM1 CA221940, R01 CA240375)
Agency for Health Care and Quality (K12 HS026369)
Licence
Copyright All Rights ReservedFaculty/School
Faculty of Medicine and Health, Sydney School of Public HealthShare